^
1d
Hyalinizing clear cell carcinoma of the nasopharyngeal minor salivary glands: an unusual case report. (PubMed, Int J Surg Case Rep)
Complete surgical excision with negative margins is the treatment of choice, and follow-up is crucial to detect recurrence. This case highlights the importance of early recognition and accurate diagnosis of HCCC to ensure curative surgical outcomes and prevent metastasis.
Journal
|
TP63 (Tumor protein 63) • GFAP (Glial Fibrillary Acidic Protein)
4d
A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing (clinicaltrials.gov)
P2, N=88, Active, not recruiting, Fudan University | Trial primary completion date: Dec 2025 --> Dec 2026
Trial primary completion date
|
HER-2 (Human epidermal growth factor receptor 2) • AR (Androgen receptor)
|
HER-2 overexpression • AR positive
|
trastuzumab rezetecan (SHR-A1811) • leuprolide acetate for depot suspension • AiRuiEn (rezvilutamide) • tizetatug rezetecan (SHR-A1921)
5d
New trial
5d
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing (clinicaltrials.gov)
P2, N=39, Recruiting, Peking Union Medical College | Trial primary completion date: Jul 2026 --> Jul 2028
Trial primary completion date
|
HER-2 (Human epidermal growth factor receptor 2) • NTRK (Neurotrophic receptor tyrosine kinase)
|
carboplatin • Perjeta (pertuzumab) • Enhertu (fam-trastuzumab deruxtecan-nxki) • Lenvima (lenvatinib) • AiRuiKa (camrelizumab) • AiTan (rivoceranib) • Piqray (alpelisib) • Irene (pyrotinib) • albumin-bound paclitaxel • abiraterone acetate • fulvestrant • Aidixi (disitamab vedotin) • exemestane • Padcev (enfortumab vedotin-ejfv) • bicalutamide • Kaitanni (cadonilimab) • goserelin acetate • Qibeian (iparomlimab/tuvonralimab) • Yidafan (ivonescimab) • iparomlimab (QL1604) • leuprolide acetate for depot suspension • Entyvio (vedolizumab)
5d
Comprehensive Immunophenotypic Profiling and Prognostic Value in Salivary Gland Mucoepidermoid Carcinoma. (PubMed, Int Dent J)
The heterogeneous immunophenotypic profiles observed in MEC reflect the biological complexity of the TME. Ki-67 was found to be a reliable indicator of tumour proliferative activity and an unfavourable prognosis. High Ki-67 expression, loss of CK19, and elevated TIL density were associated with increased recurrence risk. Although Pan-TRK expression was infrequent and not prognostically relevant, its occurrence in highly proliferative tumours suggests possible biologic interplay. Expanding immunophenotypic profiling to incorporate spatial analyses and single-cell-level characterization may deepen our understanding of MEC pathogenesis and support personalized therapeutic strategies.
Journal
|
CD8 (cluster of differentiation 8) • KRT19 (Keratin 19)
6d
Immunohistochemical assessment of cytokeratin profile in glandular odontogenic cyst and its comparison with intra-osseous and soft tissue mucoepidermoid carcinoma. (PubMed, Ann Diagn Pathol)
Cytokeratin profiling, particularly the combined evaluation of CK7, CK8, and CK19, effectively distinguishes GOC from central MEC. CK8, in particular, could serve as a reliable marker to differentiate GOC from its histopathological mimickers.
Journal
|
KRT19 (Keratin 19) • KRT20 (Keratin 20)
10d
Molecular and Microenvironmental Mechanisms of Malignant Transformation in Benign Salivary Gland Tumors: Implications for Oral Squamous Cell Carcinoma. (PubMed, Diagnostics (Basel))
Benign salivary gland tumors represent a valuable model for studying malignant transformation in head and neck oncology. Interpreting shared molecular and microenvironmental pathways may facilitate the identification of novel biomarkers and support the development of personalized diagnostic and therapeutic approaches for OSCC.
Review • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • TP53 (Tumor protein P53) • HMGA2 (High mobility group AT-hook 2) • ENG (Endoglin) • PLAG1 (PLAG1 Zinc Finger)
|
TP53 mutation • HER-2 overexpression • HER-2 mutation
10d
Phytochemical Characterization and Biological Assessment of Geranium robertianum L. Ethanolic Extract on Human Salivary Gland Carcinoma Cells. (PubMed, Antioxidants (Basel))
The GR extract exhibited moderate antibacterial activity against both Gram-positive and Gram-negative bacteria, with inhibition zones generally comparable to those of levofloxacin. However, the extract was significantly less effective against the P. aeruginosa strain. On A253 human salivary gland carcinoma cells, GR extract elicited a dose-dependent antiproliferative effect, produced morphological changes, and increased ROS and both caspase-3/7 and caspase-9 levels.
Journal
|
CASP3 (Caspase 3) • CASP9 (Caspase 9) • CASP7 (Caspase 7)
10d
Transoral Robotic Surgery for High Grade Oropharyngeal Mucoepidermoid Carcinoma With Good Outcome and Preserved Oropharyngeal Functions. (PubMed, Anticancer Res)
This case report illustrates, to the best of our knowledge, the first documented case of using TORS for MEC of the BOT involving both lingual and palatine tonsils with four years of disease-free survival, despite high histologic grade. Our case sheds light on the use of TORS for improved long-term outcome and preserved oropharyngeal functions for patients with oropharyngeal MEC.
Journal
|
MAML2 (Mastermind Like Transcriptional Coactivator 2)
11d
Diagnostic utility of EWSR1 in hyalinizing clear cell carcinoma: A systematic review and meta-analysis. (PubMed, J Stomatol Oral Maxillofac Surg)
Compared with 144 controls, HCCC exhibited a 2.16-fold higher likelihood of EWSR1 positivity, though not statistically significant (p = 0.10). These findings highlight EWSR1, particularly EWSR1-ATF1 fusion, as a sensitive molecular marker that improves diagnostic accuracy when integrated with histopathology and immunohistochemistry.
Retrospective data • Journal
|
EWSR1 (EWS RNA Binding Protein 1) • TP63 (Tumor protein 63) • ATF1 (Activating Transcription Factor 1)
12d
The Salivary Tumor That Lost Its Way: A Case Report of Sinonasal Pleomorphic Adenoma. (PubMed, Cureus)
Surgical excision remains the definitive treatment. Long-term clinical surveillance is advised, considering the risk of later recurrence or malignant transformation.
Journal
|
PLAG1 (PLAG1 Zinc Finger)
13d
Insights From Mutational and Transcriptomic Profiles in Epithelial-myoepithelial Carcinoma. (PubMed, Am J Surg Pathol)
The frequent RAS mutations and overlapping transcriptomic profiles raise important diagnostic considerations and highlight the need for integrated molecular analyses to differentiate these entities. The EMCs displayed a recurrent HRAS mutation, also observed in other head and neck tumors, and were partially clustered with the cases of BCA, suggesting potential biological similarities.
Journal
|
PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • HRAS (Harvey rat sarcoma viral oncogene homolog) • NOTCH1 (Notch 1) • STAT5B (Signal Transducer And Activator Of Transcription 5B) • CHI3L1 (Chitinase 3-like 1) • HMGA2 (High mobility group AT-hook 2) • GATA3 (GATA binding protein 3) • PLAG1 (PLAG1 Zinc Finger) • WIF1 (WNT Inhibitory Factor 1) • FBXO32 (F-Box Protein 32)
|
PIK3CA mutation • RAS mutation • HRAS mutation